All news

SPAC receives $250,000 installment, eyes Alpha AI Biotech deal

Alpha Vantage · Investing.com India · · AI-summarised by FinFlash

Drugs Made in America Acquisition II Corp. received a $250,000 installment, lifting total funding from Tal Alpha Yezum Vekidum Asakim (2003) Ltd. to $700,000 under a convertible note financing agreement. The company also disclosed a preliminary proposal to combine with Alpha AI Biotech Group, valuing Alpha at $600 million in shares, with earn-outs tied to future stock performance.

Read original source

DMII company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.